MFDS — authorised 22 August 1977
- Marketing authorisation holder: PROMIUS PHARMA LLC
- Status: likely_approved
🇰🇷 Cloderm in South Korea
MFDS authorised Cloderm on 22 August 1977
Marketing authorisation
Cloderm in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Cloderm approved in South Korea?
Yes. MFDS authorised it on 22 August 1977.
Who is the marketing authorisation holder for Cloderm in South Korea?
PROMIUS PHARMA LLC holds the South Korean marketing authorisation.